Literature DB >> 23930066

Trimethylaminuria (fish malodour syndrome) in chronic renal failure.

E Hur1, O Gungor, D Bozkurt, Smk Bozgul, F Dusunur, H Caliskan, A Berdeli, F Akcicek, A Basci, S Duman.   

Abstract

Trimethylaminuria (fish malodour syndrome) is a rare genetic metabolic disorder presented with a body odour which smells like a decaying fish. This odour is highly objectionable, that can be destructive for the social, and work life of the patient. Trimethylamine is derived from the intestinal bacterial degradation of foods that are rich of choline and carnitine. Trimethylamine is normally oxidised by the liver to odourless trimethylamine N-oxide which is excreted in the urine, so, uremia may worsen the condition. Uremia itself may cause more or less unpleasant odour. Poor uremic control may worsen the odour. We reported this case because Trimethylaminuria is not usually considered in the differential diagnosis of malodour in chronic renal failure and it is the first case that shown the association with Trimethylaminuria and chronic renal failure in the literature.

Entities:  

Keywords:  chronic renal failure; fish malodour syndrome; trimethylamine N-oxide

Year:  2012        PMID: 23930066      PMCID: PMC3738402     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  12 in total

Review 1.  Methylamine: a new endogenous modulator of neuron firing?

Authors:  Renato Pirisino; Carla Ghelardini; Gaetano De Siena; Petra Malmberg; Nicoletta Galeotti; Laura Cioni; Grazia Banchelli; Laura Raimondi
Journal:  Med Sci Monit       Date:  2005-07-25

2.  The fish odour syndrome: biochemical, familial, and clinical aspects.

Authors:  R Ayesh; S C Mitchell; A Zhang; R L Smith
Journal:  BMJ       Date:  1993-09-11

3.  The fish odor syndrome. Trimethylaminuria.

Authors:  E D Shelley; W B Shelley
Journal:  JAMA       Date:  1984-01-13       Impact factor: 56.272

4.  Trimethylaminuria: the fish malodor syndrome.

Authors:  S C Mitchell; R L Smith
Journal:  Drug Metab Dispos       Date:  2001-04       Impact factor: 3.922

5.  Biochemical profile or uremic breath.

Authors:  M L Simenhoff; J F Burke; J J Saukkonen; A T Ordinario; R Doty
Journal:  N Engl J Med       Date:  1977-07-21       Impact factor: 91.245

6.  A pharmacogenetic study of trimethylaminuria in Orientals.

Authors:  A Thithapandha
Journal:  Pharmacogenetics       Date:  1997-12

7.  Importance of aliphatic amines in uremia.

Authors:  M L Simenhoff; J J Saukkonen; J F Burke; R W Schaedler; W H Vogel; K Bovee; N Lasker
Journal:  Kidney Int Suppl       Date:  1978-06       Impact factor: 10.545

8.  Metabolism and excretion of methylamines in rats.

Authors:  J L Smith; J S Wishnok; W M Deen
Journal:  Toxicol Appl Pharmacol       Date:  1994-04       Impact factor: 4.219

9.  A genetic polymorphism of the N-oxidation of trimethylamine in humans.

Authors:  M Al-Waiz; R Ayesh; S C Mitchell; J R Idle; R L Smith
Journal:  Clin Pharmacol Ther       Date:  1987-11       Impact factor: 6.875

10.  Fish odor syndrome: trimethylaminuria with milk as chief dietary factor.

Authors:  J G Rothschild; R C Hansen
Journal:  Pediatr Dermatol       Date:  1985-11       Impact factor: 1.588

View more
  4 in total

Review 1.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

2.  A highly sensitive liquid chromatography electrospray ionization mass spectrometry method for quantification of TMA, TMAO and creatinine in mouse urine.

Authors:  Sunil Veeravalli; Kersti Karu; Ian R Phillips; Elizabeth A Shephard
Journal:  MethodsX       Date:  2017-09-28

Review 3.  Microbiota and Malodor-Etiology and Management.

Authors:  Izabella Mogilnicka; Pawel Bogucki; Marcin Ufnal
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

Review 4.  Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.

Authors:  Diede Fennema; Ian R Phillips; Elizabeth A Shephard
Journal:  Drug Metab Dispos       Date:  2016-05-17       Impact factor: 3.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.